Inspire Medical Systems (NYSE: INSP) is a medical device company that develops and commercializes an implantable neurostimulation system to treat obstructive sleep apnea. Revenue comes from the sale of the Inspire system, a surgically implanted device, to hospitals and surgical centers that perform the implantation procedure. The filing excerpts provided do not contain sufficient detail to characterize market position, competitor names, geographic revenue mix, unit volumes, or financial results for FY2025.

Revenue model

Transactional sales of implantable neurostimulation devices to hospitals and surgical centers. No subscription or recurring consumable model is described in the available filing excerpts.

Products and services

Inspire upper airway stimulation system, an implantable device for treatment of obstructive sleep apnea.

Customers and end markets

Hospitals and surgical centers performing sleep apnea procedures. End market is obstructive sleep apnea patients.

Value-chain role

Medical device manufacturer and direct commercial seller to healthcare facilities.

Source: SEC 10-K, filed 2026-02-13

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories QuidelOrtho Corp Envista Holdings Corp Globus Medical Inc Inari Medical, Inc. Masimo Corp Omnicell Inc Penumbra Inc Shockwave Medical, Inc.